These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis. Coukell AJ; Brogden RN Drugs; 1998 Apr; 55(4):585-612. PubMed ID: 9561346 [TBL] [Abstract][Full Text] [Related]
3. Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B. Chen SC; J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():57-61. PubMed ID: 11801583 [TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data. Ng TT; Denning DW Arch Intern Med; 1995 May; 155(10):1093-8. PubMed ID: 7748054 [TBL] [Abstract][Full Text] [Related]
5. Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children. Tollemar J; Klingspor L; Ringdén O Clin Microbiol Infect; 2001; 7 Suppl 2():68-79. PubMed ID: 11525221 [TBL] [Abstract][Full Text] [Related]
6. Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal amphotericin B formulation (AmBisome). Adler-Moore JP; Chiang SM; Satorius A; Guerra D; McAndrews B; McManus EJ; Proffitt RT J Antimicrob Chemother; 1991 Oct; 28 Suppl B():63-71. PubMed ID: 1778893 [TBL] [Abstract][Full Text] [Related]
7. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Tydén G Bone Marrow Transplant; 1993 Dec; 12(6):577-82. PubMed ID: 8136741 [TBL] [Abstract][Full Text] [Related]
8. Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability. Tiphine M; Letscher-Bru V; Herbrecht R Transpl Infect Dis; 1999 Dec; 1(4):273-83. PubMed ID: 11428998 [TBL] [Abstract][Full Text] [Related]
9. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients. Tollemar J; Andersson S; Ringdén O; Tydén G Mycoses; 1992; 35(9-10):215-20. PubMed ID: 1291871 [TBL] [Abstract][Full Text] [Related]
12. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. Chopra R; Blair S; Strang J; Cervi P; Patterson KG; Goldstone AH J Antimicrob Chemother; 1991 Oct; 28 Suppl B():93-104. PubMed ID: 1778896 [TBL] [Abstract][Full Text] [Related]
13. Lipid-based amphotericin B in the treatment of cryptococcosis. Viviani MA; Rizzardini G; Tortorano AM; Fasan M; Capetti A; Roverselli AM; Gringeri A; Suter F Infection; 1994; 22(2):137-42. PubMed ID: 7915255 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. Ringdén O; Meunier F; Tollemar J; Ricci P; Tura S; Kuse E; Viviani MA; Gorin NC; Klastersky J; Fenaux P J Antimicrob Chemother; 1991 Oct; 28 Suppl B():73-82. PubMed ID: 1778894 [TBL] [Abstract][Full Text] [Related]
15. Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. Coker RJ; Viviani M; Gazzard BG; Du Pont B; Pohle HD; Murphy SM; Atouguia J; Champalimaud JL; Harris JR AIDS; 1993 Jun; 7(6):829-35. PubMed ID: 8363759 [TBL] [Abstract][Full Text] [Related]
16. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Mills W; Chopra R; Linch DC; Goldstone AH Br J Haematol; 1994 Apr; 86(4):754-60. PubMed ID: 7918068 [TBL] [Abstract][Full Text] [Related]
17. Liposomal amphotericin B (AmBisome) treatment of invasive fungal infections in immunocompromised children. Ringdén O; Tollemar J Mycoses; 1993; 36(5-6):187-92. PubMed ID: 8264715 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome)--a report on 40 cases from a single centre. Chopra R; Fielding A; Goldstone AH Leuk Lymphoma; 1992; 7 Suppl():73-7. PubMed ID: 1493462 [TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. Leenders AC; Reiss P; Portegies P; Clezy K; Hop WC; Hoy J; Borleffs JC; Allworth T; Kauffmann RH; Jones P; Kroon FP; Verbrugh HA; de Marie S AIDS; 1997 Oct; 11(12):1463-71. PubMed ID: 9342068 [TBL] [Abstract][Full Text] [Related]
20. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study. Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]